Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples
Public ClinicalTrials.gov record NCT03020121. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to compare the results of the Becton Dickinson (BD) Human Papilloma Virus (HPV) Assay on the Viper LT instrument from Liquid-based cytology media diluted in HPV diluent to adjudicated histology results from biopsy.
Study identification
- NCT ID
- NCT03020121
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 28 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years and older
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2016 (Type not available)
- Primary completion
- May 2017 (Actual)
- Completion
- May 2017 (Actual)
- Last update posted
- Jan 31, 2018
2016 – 2017
United States locations
- U.S. sites
- 11
- U.S. states
- 8
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Planned Parenthood of the Rocky Mountains | Denver | Colorado | 80207 | — |
| American Pathology Partners Inc. | Denver | Colorado | 80222 | — |
| Comprehensive Clinical Trials, LLC | West Palm Beach | Florida | 33409 | — |
| Indiana University | Indianapolis | Indiana | 46202 | — |
| Sidney & Lois Eskenazi Hospital | Indianapolis | Indiana | 46202 | — |
| Transgenomics | Omaha | Nebraska | 68164 | — |
| Southwest Womens Health | Albuquerque | New Mexico | 87102 | — |
| Tricore Reference Lab | Albuquerque | New Mexico | 87102 | — |
| Research Pathology Associates, LLC | Irvington | New York | 10533 | — |
| Research Pathology Associates | Charlotte | North Carolina | 22901 | — |
| Center for Disease Detection | San Antonio | Texas | 78233 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03020121, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 31, 2018 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03020121 live on ClinicalTrials.gov.